Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 123, 87-90
Abstract
No abstract availableKeywords
Funding Information
- Dr. Josephine Feliciano
This publication has 9 references indexed in Scilit:
- Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltratesAIDS, 2018
- Immune checkpoint inhibitors in advanced non–small cell lung cancerCancer, 2017
- B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating LymphocytesClinical Cancer Research, 2017
- Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United StatesJournal of Clinical Oncology, 2015
- Cancer Treatment Disparities in HIV-Infected Individuals in the United StatesJournal of Clinical Oncology, 2014
- HIV infection, aging, and immune functionCurrent Opinion in Oncology, 2012
- HIV as an independent risk factor for incident lung cancerAIDS, 2012
- Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003Annals of Internal Medicine, 2008
- Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection DurationJAMA, 1998